Brown Virtual Lab
Research project management
Brown Virtual LabSite home

GLP-1 Education · 052

What an Observational GLP-1 Study Can Teach Us

Observational studies examine treatment as it occurs in practice.

Researchers, clinicians, and research learners · October 6, 2026

Dr. Sherry-Ann Brown, MD, PhD, FACC, FAHA

The research question

Observational studies examine treatment as it occurs in practice. They can describe prescribing patterns, access, persistence, and outcomes among groups whose experiences may receive limited attention in trials. Their value grows when authors define eligibility, treatment initiation, comparison groups, and outcome measurement precisely. The reader should follow the study timeline from entry through exposure and follow-up.

How to interpret the evidence

Treatment choice often reflects clinical need, prior therapies, insurance coverage, and patient preference. Those same factors may influence outcomes. Statistical adjustment addresses measured differences according to the model used; remaining differences require thoughtful interpretation. Matching improves comparability on the included characteristics, while the quality and completeness of those characteristics remain central to the analysis.

The published retrospective cohort study of GLP-1 medications and hair loss illustrates an observational design used to investigate an emerging safety question.

A further concern is healthcare contact. People who return frequently may have more opportunities to receive a diagnosis in their record. If one treatment group has more follow-up visits, observed outcome differences may partly reflect detection. Assessing utilization before and after treatment can help researchers explain this possibility and design a more informative comparison.

Practice the appraisal

Original appraisal exercise: sketch two patients receiving different therapies in routine care. Consider obesity severity, prior medication response, insurance, nutritional intake, and existing hair concerns as possible influences on their treatment choices. These are hypothetical factors for a design discussion. Find which corresponding variables the actual cohort measured before exposure. Examine whether matching balanced those variables and whether follow-up intensity differed. Write the resulting association in one sentence, then identify the most important clinical factor that the records may capture poorly. This links statistical adjustment to the real treatment pathway.

Apply the lesson

For an observational journal club, sketch the clinical decision that created each treatment group. Consider who had access to treatment and who returned for follow-up. A concise explanation of these pathways can make the analytic limitations understandable. The final evidence brief should identify the measured association and explain which design features support confidence, which factors remain uncertain, and what additional research could strengthen the conclusion.

Sources

  1. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study

Sources consulted October 6, 2026. Evidence interpretation and proposed exercises are identified in the text.

PURPOSE IN PRACTICE

Develop people while developing evidence.

The laboratory joins rigorous inquiry, distributed leadership, peer learning, transparent contribution, mentorship, and scholarly work that prepares future researchers to serve well.

Awaken the heartClarify purposeSteward giftsDevelop peopleMultiply influence